Statement From MariMed CEO And President Jon Levine Regarding The Drug Enforcement Administration’s Decision To Recategorize Cannabis To Schedule III

 Statement From MariMed CEO And President Jon Levine Regarding The Drug Enforcement Administration’s Decision To Recategorize Cannabis To Schedule III

NORWOOD, Mass., April 30, 2024 (GLOBE NEWSWIRE) — The following is a statement from Jon Levine, CEO and President of leading multi-state cannabis operator, MariMed Inc. (MariMed) (CSE: MRMD) (OTCQX:…